Impact of the longitudinal evolution of impaired fasting glucose on cardio-kidney-metabolic multimorbidity

• by Guanlin Chen, Hong Zheng, Yuxian Wang, Man Gui, Zhen He, Zekai Chen, Shouling Wu, Youren Chen

• June 16, 2026

Association of the glucose metabolism continuum (fasting plasma glucose/HbA1c) with tear-film stability and secretion: ocular surface evidence across non-diabetes, prediabetes, and diabetes

• by Huan Xiang, Zengsheng Zhou

• April 13, 2026

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

• by Kerri Miller

• March 11, 2026

• 5 min

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

• by Kathryn Wighton

• May 13, 2026

• 5 min